Characteristics | Healthy control | Chronic hepatitis B | p valueA, B | HBV DNA IU/mL | p valueA, B1 | p valueA, B2 | p valueB1, B2 | |
---|---|---|---|---|---|---|---|---|
< 2000 | ≥ 2000 | |||||||
Group A | Group B | Group B1 | Group B2 | |||||
Number | 57 | 57 | 40 | 17 | ||||
Age (years)* | 41.7 (7.91) | 49.5 (9.64) | < 0.001 | 51.3 (9.01) | 45.2 (9.9) | < 0.001 | 0.132 | 0.039 |
Male (%) | 23 (40.4) | 37 (64.9) | 0.009 | 27 (67.5) | 10 (58.8) | 0.008 | 0.179 | 0.530 |
Current smoker (%) | 1 (1.8) | 8 (14) | < 0.001 | 4 (10%) | 4 (23.5) | < 0.001 | < 0.001 | 0.324 |
BMI (kg/m2)* | 22.93 (3.11) | 23.49 (3.05) | 0.326 | 23.74 (2.96) | 22.91 (3.27) | 0.196 | 0.983 | 0.372 |
HBeAg (%) | – | 6 (10.5) | – | 0 | 6 (35.3) | – | – | < 0.001 |
HbeAb (%) | – | 49 (86.0) | – | 39 (97.5) | 10 (58.8) | – | – | < 0.001 |
Previous antiviral agents (%) | – | 3 (5.3) | – | 0 | 3 (17.6) | – | – | 0.023 |
Lab findings (mean, SD) | ||||||||
WBC | 6116 (1407) | 5389 (1441) | 0.007 | 5443 (1566) | 5261 (1125) | 0.029 | 0.025 | 0.667 |
Platelet | 273,000 (59,060) | 214,000 (51,740) | < 0.001 | 214,000 (54,330) | 216,000 (46,600) | < 0.001 | < 0.001 | 0.913 |
HbA1c | 5.46† (0.28) | 5.46† (0.38) | 0.962 | 5.46‡ (0.33) | 5.46 (0.51) | 0.930 | 0.979 | 0.953 |
Total bilirubin | 0.68 (0.25) | 0.91 (0.39) | < 0.001 | 0.92 (0.39) | 0.89 (0.40) | < 0.001 | 0.052 | 0.814 |
AST | 21.18 (6.30) | 23.86 (8.96) | 0.067 | 22.98 (8.3) | 25.94 (10.33) | 0.228 | 0.086 | 0.304 |
ALT | 22.93 (14.02) | 27.51 (24.13) | 0.218 | 25.85 (25.11) | 31.41 ( 21.84) | 0.466 | 0.146 | 0.407 |
Lipid profile (mean, SD) | ||||||||
Total cholesterol | 190.18 (34.14) | 182.19 (32.64) | 0.205 | 182.48 (32.62) | 181.53 (33.67) | 0.268 | 0.361 | 0.923 |
LDL-cholesterol | 128.39 (33.83) | 117.79† (28.50) | 0.075 | 120.46‡ (28.52) | 111.65 (28.34) | 0.233 | 0.068 | 0.294 |
HDL-cholesterol | 63.28 (15.83) | 57.41† (17.35) | 0.063 | 53.23‡ (13.83) | 67.00 (20.97) | 0.002 | 0.434 | 0.021 |